SoundHound AI insider notice: 41,167 shares, $749,239 value
Rhea-AI Filing Summary
SoundHound AI insider plans a scheduled sale of 41,167 common shares, representing currently listed securities with an aggregate market value of $749,239.40. The filer reports the shares were acquired as Performance Stock Units on 06/20/2025 and intends an approximate sale date of 10/08/2025 on NASDAQ. The filing shows 375,150,890 shares outstanding, which provides context for the relative size of the proposed sale.
The notice also discloses two reported sales by the same account in September: 36,185 shares on 09/24/2025 for $646,261.21 and 42,119 shares on 09/22/2025 for $673,971.39, totaling $1,320,232.60 in gross proceeds. The filer attests there is no undisclosed material adverse information and references possible reliance on a Rule 10b5-1 plan.
Positive
- Shares were acquired as Performance Stock Units on 06/20/2025, indicating compensation-related origin
- Proposed sale size is small versus total outstanding shares (41,167 vs 375,150,890)
Negative
- Recent insider sales in September totaled 78,304 shares for $1,320,232.60, showing ongoing dispositions
- Filing indicates a planned sale on 10/08/2025, which may add supply to the market on that date
Insights
Insider sale is small relative to the float but worth monitoring for execution timing.
The proposed sale of 41,167 shares valued at $749,239.40 is a routine Rule 144 notice tied to securities acquired as Performance Stock Units on 06/20/2025. Against 375,150,890 shares outstanding, this sale represents a de minimis percentage of total equity.
Recent September disposals totaling $1,320,232.60 show the account has been liquidating holdings; if further scheduled sales follow a 10b5-1 plan, market impact should be limited. Investors should note the approximate sale date 10/08/2025 and monitor aggregated insider activity over the next quarter.
Disclosure aligns with Rule 144 and includes a representation about material non-public information.
The notice explicitly states the securities were acquired from the issuer and the signer represents no undisclosed material adverse information as of any adopted 10b5-1 plan date. That attestation is standard and required to rely on safe-harbor trading plans.
Material governance considerations are limited: confirm whether the sales follow a documented 10b5-1 plan and check future Form 4/Form 144 filings for cumulative insider dispositions over rolling 3- to 12-month windows.